Sara Fancelli

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario

Luca Cantini, Giulia Mentrasti, Gian Luigi Russo et al. · ESMO Open · 2022 · 62 citations · Full text

Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study

Agnese Paderi, Sara Fancelli, Enrico Caliman et al. · Current Oncology · 2021 · 49 citations · Full text

Results of the observational prospective RealFLOT study

Elisa Giommoni, Daniele Lavacchi, Giuseppe Tirino et al. · BMC Cancer · 2021 · 42 citations · Full text

Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study

Matteo Lambertini, Arlindo R. Ferreira, Antonio Di Meglio et al. · Clinical Breast Cancer · 2017 · 33 citations

Nursing, Breast Oncology, Medicine +7

Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy

Enrico Caliman, Sara Fancelli, Carlotta Ottanelli et al. · Cancer Treatment and Research Communications · 2022 · 23 citations · Full text